244 related articles for article (PubMed ID: 31326306)
1. Bone Mineral Density in Transgender Individuals After Gonadectomy and Long-Term Gender-Affirming Hormonal Treatment.
Dobrolińska M; van der Tuuk K; Vink P; van den Berg M; Schuringa A; Monroy-Gonzalez AG; García DV; Schultz WCMW; Slart RHJA
J Sex Med; 2019 Sep; 16(9):1469-1477. PubMed ID: 31326306
[TBL] [Abstract][Full Text] [Related]
2. Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen.
Wiepjes CM; de Jongh RT; de Blok CJ; Vlot MC; Lips P; Twisk JW; den Heijer M
J Bone Miner Res; 2019 Mar; 34(3):447-454. PubMed ID: 30537188
[TBL] [Abstract][Full Text] [Related]
3. Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen.
Vlot MC; Wiepjes CM; de Jongh RT; T'Sjoen G; Heijboer AC; den Heijer M
J Bone Miner Res; 2019 Oct; 34(10):1862-1872. PubMed ID: 31099910
[TBL] [Abstract][Full Text] [Related]
4. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
[TBL] [Abstract][Full Text] [Related]
5. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
6. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
[TBL] [Abstract][Full Text] [Related]
7. Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data.
Ristori J; Cocchetti C; Castellini G; Pierdominici M; Cipriani A; Testi D; Gavazzi G; Mazzoli F; Mosconi M; Meriggiola MC; Cassioli E; Vignozzi L; Ricca V; Maggi M; Fisher AD
J Sex Med; 2020 Jan; 17(1):142-151. PubMed ID: 31735612
[TBL] [Abstract][Full Text] [Related]
8. Study of Effects of Gender-Affirming Hormone Therapy on Bone Mineral Density in Individuals with Gender Dysphoria.
Bobba R; Kalra P; Dharmalingam M
Indian J Endocrinol Metab; 2023; 27(6):486-491. PubMed ID: 38371188
[TBL] [Abstract][Full Text] [Related]
9. Impact of cross-sex hormone therapy on bone mineral density and body composition in transwomen.
Fighera TM; da Silva E; Lindenau JD; Spritzer PM
Clin Endocrinol (Oxf); 2018 Jun; 88(6):856-862. PubMed ID: 29630732
[TBL] [Abstract][Full Text] [Related]
10. Gender-Affirming Hormone Therapy Modifies the CpG Methylation Pattern of the ESR1 Gene Promoter After Six Months of Treatment in Transmen.
Fernández R; Ramírez K; Gómez-Gil E; Cortés-Cortés J; Mora M; Aranda G; Zayas ED; Esteva I; Almaraz MC; Guillamon A; Pásaro E
J Sex Med; 2020 Sep; 17(9):1795-1806. PubMed ID: 32636163
[TBL] [Abstract][Full Text] [Related]
11. Gender-Affirming Hormone Treatment Induces Facial Feminization in Transwomen and Masculinization in Transmen: Quantification by 3D Scanning and Patient-Reported Outcome Measures.
Tebbens M; Nota NM; Liberton NPTJ; Meijer BA; Kreukels BPC; Forouzanfar T; Verdaasdonk RM; den Heijer M
J Sex Med; 2019 May; 16(5):746-754. PubMed ID: 30926514
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in complete androgen insensitivity syndrome and the timing of gonadectomy.
King TFJ; Wat WZM; Creighton SM; Conway GS
Clin Endocrinol (Oxf); 2017 Aug; 87(2):136-140. PubMed ID: 28493277
[TBL] [Abstract][Full Text] [Related]
13. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
[TBL] [Abstract][Full Text] [Related]
14. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
Rahim A; Holmes SJ; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
[TBL] [Abstract][Full Text] [Related]
15. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
[TBL] [Abstract][Full Text] [Related]
16. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
17. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review of the Long-Term Effects of Transgender Hormone Therapy on Bone Markers and Bone Mineral Density and Their Potential Effects in Implant Therapy.
Delgado-Ruiz R; Swanson P; Romanos G
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31159456
[TBL] [Abstract][Full Text] [Related]
19. Bone geometry and trabecular bone score in transgender people before and after short- and long-term hormonal treatment.
Wiepjes CM; Vlot MC; de Blok CJM; Nota NM; de Jongh RT; den Heijer M
Bone; 2019 Oct; 127():280-286. PubMed ID: 31271934
[TBL] [Abstract][Full Text] [Related]
20. Does (mis)use of industrial liquid silicone implants interfere with bone mineral density in transgender women?
Fighera TM; da Silva ED; Borba GDS; Spritzer PM
Arch Osteoporos; 2020 Sep; 15(1):149. PubMed ID: 32964330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
